The Bispecific Revolution: How Dual-Targeting Antibodies Are Reshaping Therapy and Creating a Manufacturing Bottleneck
The biopharmaceutical industry is in the throes of a revolution, one engineered with atomic precision in the heart of a protein. This is the era of the bispecific antibody (BsAb), a class of therapeutics that has moved decisively from the cutting edge of scientific research to the front lines of clinical practice. With a […]